ATE311193T1 - Attenuierte pestiviren - Google Patents

Attenuierte pestiviren

Info

Publication number
ATE311193T1
ATE311193T1 AT02003407T AT02003407T ATE311193T1 AT E311193 T1 ATE311193 T1 AT E311193T1 AT 02003407 T AT02003407 T AT 02003407T AT 02003407 T AT02003407 T AT 02003407T AT E311193 T1 ATE311193 T1 AT E311193T1
Authority
AT
Austria
Prior art keywords
pestiviruses
attenuate
attenuate pestiviruses
Prior art date
Application number
AT02003407T
Other languages
English (en)
Inventor
Gregor Meyers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE311193T1 publication Critical patent/ATE311193T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13Tumour cells, irrespective of tissue of origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT02003407T 1998-06-05 1999-05-26 Attenuierte pestiviren ATE311193T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110356A EP0965639A1 (de) 1998-06-05 1998-06-05 Attenuierte Pestiviren

Publications (1)

Publication Number Publication Date
ATE311193T1 true ATE311193T1 (de) 2005-12-15

Family

ID=8232074

Family Applications (3)

Application Number Title Priority Date Filing Date
AT02003408T ATE316380T1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren
AT02003407T ATE311193T1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren
AT99926430T ATE286131T1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02003408T ATE316380T1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99926430T ATE286131T1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren

Country Status (23)

Country Link
EP (5) EP0965639A1 (de)
JP (3) JP4632540B2 (de)
KR (1) KR100637940B1 (de)
CN (2) CN101085346A (de)
AR (3) AR020084A1 (de)
AT (3) ATE316380T1 (de)
AU (1) AU769823C (de)
BR (2) BR9911619B1 (de)
CA (1) CA2330241C (de)
CO (1) CO5050392A1 (de)
CZ (3) CZ301570B6 (de)
DE (3) DE69928700T2 (de)
DK (3) DK1084251T3 (de)
ES (3) ES2253457T3 (de)
HU (3) HU228469B1 (de)
NZ (1) NZ509228A (de)
PE (1) PE20000552A1 (de)
PL (2) PL202509B1 (de)
PT (2) PT1203813E (de)
SI (3) SI1084251T1 (de)
SK (3) SK287626B6 (de)
TR (3) TR200003622T2 (de)
WO (1) WO1999064604A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP1104676A1 (de) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Sichere abgeschwächte Rinderdiarrhöeviren zur Verwendung in trächtigen Kühen
EP1149901B1 (de) * 2000-04-21 2006-04-05 Akzo Nobel N.V. Pestivirus Mutanten und dessen enthaltende Impfstoffe
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
JP2012507537A (ja) 2008-10-31 2012-03-29 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド マイコプラズマ・ボビスの抗原を含む種々の抗原の多価ワクチン組成物における使用
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CN101915837B (zh) * 2010-07-28 2013-07-03 中国兽医药品监察所 一种猪瘟兔化弱毒活疫苗效力检验方法
EP2618841B1 (de) 2010-09-21 2016-10-19 Intervet International B.V. Bvdv-impfstoff
CN103882051B (zh) * 2014-03-20 2016-04-06 北京市农林科学院 一种检测猪瘟病毒抗体的elisa方法及检测试剂盒
WO2020211801A1 (en) * 2019-04-18 2020-10-22 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Recombinant classical swine fever virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000004I1 (de) * 1986-01-27 2007-05-24 Schering Plough Ltd Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe

Also Published As

Publication number Publication date
EP1203812B1 (de) 2005-11-30
JP5755265B2 (ja) 2015-07-29
DK1084251T3 (da) 2005-04-11
KR100637940B1 (ko) 2006-10-23
CA2330241A1 (en) 1999-12-16
SI1203813T1 (sl) 2006-06-30
TR200103666T2 (tr) 2002-03-21
JP5247770B2 (ja) 2013-07-24
CZ20004533A3 (cs) 2001-07-11
TR200103664T2 (tr) 2002-06-21
PE20000552A1 (es) 2000-07-14
SI1203812T1 (sl) 2006-04-30
SK287014B6 (sk) 2009-09-07
CZ301570B6 (cs) 2010-04-21
DE69929544T2 (de) 2006-07-20
EP0965639A1 (de) 1999-12-22
ES2235488T3 (es) 2005-07-01
DE69922953D1 (de) 2005-02-03
HUP0102707A2 (hu) 2001-11-28
HU228468B1 (en) 2013-03-28
DK1203812T3 (da) 2006-04-10
CA2330241C (en) 2010-09-21
PT1203813E (pt) 2006-06-30
SK18232000A3 (sk) 2001-05-10
JP2002517250A (ja) 2002-06-18
WO1999064604A2 (en) 1999-12-16
ES2257476T3 (es) 2006-08-01
JP2010259445A (ja) 2010-11-18
BR9911619A (pt) 2001-10-02
HU228469B1 (en) 2013-03-28
KR20010071406A (ko) 2001-07-28
PL202509B1 (pl) 2009-06-30
DK1203813T3 (da) 2006-05-22
WO1999064604A3 (en) 2000-01-27
TR200003622T2 (tr) 2001-06-21
CN100374563C (zh) 2008-03-12
BRPI9917787B1 (pt) 2016-09-06
HUP0102707A3 (en) 2008-04-28
EP1203813A3 (de) 2004-02-04
CN101085346A (zh) 2007-12-12
CO5050392A1 (es) 2001-06-27
HU228471B1 (en) 2013-03-28
ATE286131T1 (de) 2005-01-15
PL348019A1 (en) 2002-05-06
DE69929544D1 (de) 2006-04-13
CZ301569B6 (cs) 2010-04-21
DE69928700T2 (de) 2006-06-22
JP2013099357A (ja) 2013-05-23
AU769823C (en) 2004-11-25
PL202161B1 (pl) 2009-06-30
AR071880A2 (es) 2010-07-21
EP1084251B1 (de) 2004-12-29
AR020084A1 (es) 2002-04-10
ES2253457T3 (es) 2006-06-01
AR071881A2 (es) 2010-07-21
CZ301494B6 (cs) 2010-03-24
PT1084251E (pt) 2005-03-31
EP1203812A3 (de) 2004-02-04
JP4632540B2 (ja) 2011-02-16
EP1614423A3 (de) 2008-01-30
AU769823B2 (en) 2004-02-05
BR9911619B1 (pt) 2013-11-12
EP1203813A2 (de) 2002-05-08
SK287625B6 (sk) 2011-04-05
DE69922953T2 (de) 2005-05-19
SK287626B6 (sk) 2011-04-05
EP1203812A2 (de) 2002-05-08
SI1084251T1 (de) 2005-08-31
ATE316380T1 (de) 2006-02-15
EP1614423A2 (de) 2006-01-11
CN1304452A (zh) 2001-07-18
EP1203813B1 (de) 2006-01-25
NZ509228A (en) 2003-12-19
AU4369299A (en) 1999-12-30
EP1084251A2 (de) 2001-03-21
DE69928700D1 (de) 2006-01-05

Similar Documents

Publication Publication Date Title
NO984956D0 (no) Brenner
FI990534A (fi) CT-kuvauslaite
DE69808145T2 (de) Tintenbehälternachfüllsystem
ID30142A (id) Filter lubang
ATE311193T1 (de) Attenuierte pestiviren
DE59912684D1 (de) Folienförmige wirkstoffträger
DE59914216D1 (de) Prüfsonde-Antriebsvorrichtung
NO20000746D0 (no) Brenner
NO20010660D0 (no) Isolator
DE69926628D1 (de) Turbidimeterkalibrierung-überprüfungsvorrichtung
ID28624A (id) Turunan 2-fenilpiran-4-on
DE69839736D1 (de) Pseudostereophonie-gerät
IS5799A (is) FKBP latar
DE69903384T2 (de) Insektentöttendes Gerät
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE59912793D1 (de) Schwingungsdämpfer
DE19842103B4 (de) Stanznietzuführung
DE59808995D1 (de) Endomikroskopsystem
PT1076660E (pt) (4-bromopirazol-3-il)-benzazolos substituidos
DE59704877D1 (de) Mikrogalvanisch hergestelltes bauteil
DE59905583D1 (de) Elektromechanisches bauteil
DE69912869D1 (de) Selbstinduktives Bauelement
ATA65497A (de) Bauelement
DE19983031T1 (de) Kochvorrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1203812

Country of ref document: EP